News – Page 1064 – Endpoints News

SIGN UP

Parker Institute-allied Tessa grabs an $80M round for its next-gen cancer cell therapies

8 years ago

FDA rolls out an early and historic OK for Spark's pioneering gene therapy -- now let's talk price

8 years ago

Roche strikes an €87.5M discovery deal with Confo; Onconova out-licenses preclinical drug to China's HanX

8 years ago

Array joins Pfizer on anti-cancer combos, the latest in a string of binimetinib combinations

8 years ago

Is Roche's pRED finally ready to step out from behind Genentech for its closeup? Probably not

8 years ago

Shire hit by a setback as Hunter syndrome drug fails late-stage study

8 years ago

Stepping up behind Sanofi, Genentech rolls the DiCE on a new small molecule discovery pact

8 years ago

Aerie bags an early OK for its self-described blockbuster glaucoma drug Rhopressa, recruiting 100 reps

8 years ago

Apotex founder and wife's death now suspected homicide; Spectrum CEO Rajesh Shrotriya fired

8 years ago

On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo

8 years ago

Severe job cuts at Teva incite massive worker strikes, shutting Israel down

8 years ago

What’s the big hurry, Novartis? Pharma giant scores a PRV shortcut for $130M

8 years ago

Allergan and Gedeon Richter ready to knock on FDA's door after a positive PhIII for cariprazine in bipolar depression

8 years ago

AbbVie vet John Leonard moves up to the helm at CRISPR/Cas9 pioneer Intellia, focused on looming human studies

8 years ago

Boehringer antes up on a €627.5M deal for rights to Autifony’s schizophrenia drugs

8 years ago

Bain leads big $70M round as Aptinyx plunges deeper into NMDA work

8 years ago

Andy Boyer joins Teva exodus; Achaogen shuffles executive lineup

8 years ago

Celgene forges cancer pact with CRT; FDA OKs Pfizer's Xeljanz as treatment for psoriatic arthritis

8 years ago

Four months after patient death, FDA's hold lifted on Alnylam's fitusiran

8 years ago

The 50 most active biotech VC funds in 2017

8 years ago

Amicus CEO lobbied FDA to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years

8 years ago

Grail taps Genentech vet Jennifer Cook as CEO, building expectations for 2018

8 years ago

Novartis oncology CEO Bruno Strigini is calling it quits

8 years ago

One of Merck's pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK

8 years ago

First page Previous page 1061 1062 106310641065 1066 1067 Next page Last page